PHISO-SCRUB Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phiso-scrub, and when can generic versions of Phiso-scrub launch?
Phiso-scrub is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in PHISO-SCRUB is hexachlorophene. There are seven drug master file entries for this compound. Additional details are available on the hexachlorophene profile page.
Summary for PHISO-SCRUB
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 80 |
Patent Applications: | 2,995 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHISO-SCRUB at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PHISO-SCRUB
US Patents and Regulatory Information for PHISO-SCRUB
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | PHISO-SCRUB | hexachlorophene | SPONGE;TOPICAL | 017446-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |